Product Information
DESVENLAFAXINE ER 50 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $3.7552 per EA under NDC 63304019130. Its NADAC has been published 576 times since Nov 28, 2013.
FDA first approved this application on Mar 4, 2013.
The High Outlier badge above means this manufacturer's average price in the Desvenlafaxine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304019130
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DESVENLAFAXINEApproval Type
New Drug (NDA)
FDA Application
NDA204150FDA Approved
3/4/2013
On Market Since
3/5/2013
Pharmacological Classes
Price Statistics
The NADAC for DESVENLAFAXINE ER 50 MG TAB has been published 576 times since Nov 28, 2013, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7552 per EA |
|---|---|
| All-time high | $4.4129 (Aug 12, 2015) |
| All-time low | $3.3436 (Jun 19, 2024) |
| 52-week high | $3.8538 |
| 52-week low | $3.7552 |
| Median price | $4.0079 |
| Average price | $3.9713 |
| Largest weekly change | +20.2% (Dec 17, 2014) |
| Weeks tracked | 576 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desvenlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESVENLAFAXINE ER 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DESVENLAFAXINE ER 50 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $3.7552 per EA (NDC 63304019130), effective Sep 30, 2026.
How has the price of DESVENLAFAXINE ER 50 MG TAB changed over time?
Over the history we have for it, the NADAC for DESVENLAFAXINE ER 50 MG TAB has declined 10.5%. It has been tracked across 576 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DESVENLAFAXINE ER 50 MG TAB?
Since Nov 28, 2013, the NADAC for DESVENLAFAXINE ER 50 MG TAB has ranged from a low of $3.3436 (Jun 19, 2024) to a high of $4.4129 (Aug 12, 2015), with a median of $4.0079 per EA.
Are there cheaper alternatives to DESVENLAFAXINE ER 50 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DESVENLAFAXINE SUCCNT ER 50 MG, is $0.3965 per EA — about 89% below DESVENLAFAXINE ER 50 MG TAB.
Who manufactures DESVENLAFAXINE ER 50 MG TAB?
DESVENLAFAXINE ER 50 MG TAB (NDC 63304019130) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.